Gate2Brain
  • Home
  • Company
    • Mission & vision
    • Awards & Recognitions
    • Seals & Product Designations
    • Supported by
  • About us
    • Founders
    • Team
    • Advisory board
    • Values
  • Technology
    • Scientific Publications
  • Pipeline-Proof of Concept
  • Investors
  • News & Media
  • Contact
  • Menu Menu

Winner of the Innovator’s Pitch Challenge Award at RESI Europe 2024

Funding & Breakthroughs, News, timeline

At Gate2Brain, we are thrilled to announce that we have been granted the Innovator’s Pitch Challenge Award at RESI Europe 2024, which made its debut in Barcelona.

We want to extend our heartfelt congratulations to YSOTOPE Theranostics and DyCare, as well as all the participants who made the competition so inspiring.

The event featured engaging pitch sessions and insightful debates, providing a valuable platform for innovation and collaboration.

We would like to thank the organizers and institutions that made this significant event possible in Barcelona:#RESIEurope was held in Barcelona thanks to the collaboration of the event’s organizer, Life Science Nation, with #Biocat as the local co-organizer, the Barcelona City Council (Ajuntament de Barcelona) and the Government of Catalonia (Generalitat de Catalunya), and support from Biotechgate

It was a fantastic day to share our project, mission, and investment opportunities, while also building bridges and welcoming RESI to Europe!!

Together, we can empower tomorrow’s solutions today. Gate2Brain, bringing medicines beyond barriers.

 

June 18, 2024/by noticias
Tags: award, pitch, RESI
Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on WhatsApp
  • Share on LinkedIn
  • Share by Mail
https://gate2brain.com/wp-content/uploads/2024/06/Resi.png 380 520 noticias https://gate2brain.com/wp-content/uploads/2020/12/Logo-Gate1Brain500pxGrueso.png noticias2024-06-18 12:48:492025-02-19 08:59:56Winner of the Innovator’s Pitch Challenge Award at RESI Europe 2024
You might also like
Gate2Brain participated on June 29 at The Milner Therapeutics Institute (MTI) Pitch Day 🗣️at the University of Cambridge, the cradle of cancer research. The MTI Pitch Day is a great initiative designed to highlight companies like us to investors, to create connections between academic entrepreneurship and investment to promote therapeutic companies. A great event that pulls together on one side academic, preclinical and research and on the other industry in an effort to push forward collaborative drug development and increase the standard of patient careGate2Brain at MIT Pitch Day at University of Cambridge
G2B among the 6 finalist startups at the Trans-Atlantic Angel Conference
Plug & Play Biotech Pitch
Navigating the ecosystem of pharma companies and investors at JP Morgan-RESI
Breaking Barriers in Science: The Journey of Meritxell Teixidó and Gate2Brain
Gate2Brain will be attending RESI JMP San Francisco 2025
GATE2BRAIN winner of the Barcelona Activa Pre-acceleration competitionBarcelona ActivaGate2Brain winner of the Barcelona Activa Pre-Acceleration Competition
Biotech New Frontiers Award 2022Gate2BrainG2B awarded with Biotech New Frontiers 2022

CATEGORIES

  • Advisory Board
  • Events
  • Funding & Breakthroughs
  • Interviews
  • Media & Press
  • Media Coverage
  • News
  • Podcasts
  • Press releases
  • Research & Publications
  • Sin categoría
  • Video Content

Events

  • Bioengineering the Future of Drug Delivery workshop – PortoApril 8, 2025 - 10:03
  • Gate2Brain at the 2nd Peptide-Based Therapeutics Summit | BostonMarch 26, 2025 - 15:34
  • 4YFN 2025March 6, 2025 - 19:45
  • Keystone Symposia on Drug Delivery to the Brain: Emerging ModalitiesFebruary 21, 2025 - 11:10
  • Gate2Brain at ACCELERATE 2025: A Decade of Impact and Future Innovations in Pediatric OncologyFebruary 20, 2025 - 10:19

SOCIAL

  • linkedin
  • youtube
Gate2Brain

Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier. We use a radically innovative peptide-based patented technology.

Where to find us

Barcelona Scientific Park
Baldiri Reixac, 4-8, Torre I
08028 Barcelona, Spain
info@gate2brain.com

Social

  • linkedin
  • youtube
© Copyright –Edisenius
  • Privacy Policy
  • Legal Notice
  • Cookie Policy
Fortifying CDMO Partnerships Elevating GMP ProtocolsMeritxell Teixidó, Entrepreneurial Advisory Board member of The Peptide Drug...
Scroll to top
Manage Cookie Consent
This Website uses proprietary and third-party cookies to improve services and facilitate browsing. You can obtain further information about the cookies this site uses and how to limit them in the
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
View preferences
{title} {title} {title}